Conversely, in patients with peanut anaphylaxis undergoing peanut antigen oral immunotherapy, EGID has been a well-described adverse outcome (27), suggesting that chronic antigen exposure drives the differentiation of IL-5− into IL-5+ Th2 cells. The gene discussed is IL5; the disease is eosinophilic gastrointestinal disease.